Elemental alteration, iron overloading and metallothionein induction in experimental hepatocarcinogenesis: A free radical-mediated process?

Toxicology Letters

Volumn 203, Issue 1, 2011, Pages 40-47

  Mishra, Debadutta ^a   Sudarshan, Mathummal ^a   Chakraborty, Anindita ^a  

^a UGC DAE CONSORTIUM FOR SCIENTIFIC RESEARCH   (India)

Author keywords

Carcinogenesis; Iron accumulation; Metallothionein; Oxidative stress; P Dimethylaminoazobenzene (p DAB)

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; ACONITATE HYDRATASE; CARCINOGEN; COPPER; FREE RADICAL; IRON; METALLOTHIONEIN; REACTIVE OXYGEN METABOLITE; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEEDING; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOCRIT; IRON OVERLOAD; LIPID PEROXIDATION; LIVER; LIVER CARCINOGENESIS; LIVER TUMOR; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLEEN WEIGHT; UPREGULATION;

ANIMALS; ANTIOXIDANTS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FREE RADICALS; IRON; IRON OVERLOAD; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METALLOTHIONEIN; MICE; OXIDATIVE STRESS; P-DIMETHYLAMINOAZOBENZENE; REACTIVE OXYGEN SPECIES; SEX FACTORS; TIME FACTORS; TRACE ELEMENTS; UP-REGULATION;

MUS; RODENTIA;

EID: 79954858901     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.02.018     Document Type: Article

References (56)

1. Aebi H. Catalase in vitro. Methods in Enzymology 1984, 105:121-126. Academic Press, New York.
2. Agadjanyan M., Vasilevko V., Ghochikyan A., Berns P., Kesslak P., Settineri R.A., Nicolson G.L. Nutritional supplement (NF Factor™) restores mitochondrial function and reduces moderately severe fatigue in aged subjects. J. Chronic Fatigue Syndr. 2003, 11:23-36.
3. Aydinlik H., Nguyen T.D., Moennikes O., Buchmann A., Schwarz M. Selective pressure during tumor promotion by Phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene 2001, 20:7812-7816.
4. Bannasch P., Haertel T., Su Q. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol. Pathol. 2003, 31:134-139.
5. Biswas S.J., Khuda-Bukhsh A.R. Evaluation of protective potentials of a potentized homeopathic drug, Chelidonium majus, during azo dye induced hepatocarcinogenesis in mice. Indian J. Exp. Biol. 2004, 42:698-714.
6. Biswas S.J., Khuda-Bukhsh A.R. Cytotoxic and genotoxic effects of the azo-dye p-dimethylaminoazobenzebe in mice: a time-course study. Mutat. Res. 2005, 587:1-8.
7. Bonkovsky H.L. Iron and the liver. Am. J. Med. Sci. 1991, 301:32-43.
8. Bremner I., Beattie J.H. Metallothionein and the trace minerals. Annu. Rev. Nutr. 1990, 10:63-83.
9. Britton R.S. Metal-induced hepatotoxicity. Semin. Liver. Dis. 1996, 16:3-12.
10. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods in Enzymology 1978, vol. 52:302-310. Academic Press, New York.
11. Carvalho M.L., Marques A.F. X-ray fluorescence spectrometry: applications in trace elements studies in human tissues from patients with cirrhosis. X-Ray Spectrom. 2001, 30:397-402.
12. Cerutti P.A. Prooxidant status and tumor promotion. Science 1985, 227:375-381.
13. Cherian M.G. The significance of the nuclear and cytoplasmic localisation of metallothionein in human liver and tumor cells. Environ. Health Perspect. 1994, 102:131-135.
14. Cousins R.J. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol. Rev. 1985, 65:238-309.
15. Cragg L., Hebbel R.P., Miller W., Solovey A., Selby S., Enright H. The iron chelator L1 potentiates oxidative DNA damage in iron-loaded liver cells. Blood 1998, 92:632-638.
16. Drapier J.C., Hibbs J.B. Aconitases: a class of metalloproteins highly sensitive to nitric oxide synthesis. Nitric Oxide, Part B. Physiological and Pathological Processes. Methods in enzymology 1996, vol. 269:26-36. Academic Press, San Diego.
17. Emily H.O., Ames B.N. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFκB, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc. Natl. Acad. Sci. 2002, 99:16770-16775.
18. Farber E. The sequential analysis of liver cancer induction. Biochim. Biophys. Acta 1980, 605:149-166.
19. Fischer J.G., Glauert H.P., Yin T., Sweeney-Reeves M.L., Larmonier N., Black M.C. Moderate iron overload enhances lipid peroxidation in livers and rats, but does not affect NF-κB activation induced by peroxisome proliferators Wy-14643. J. Nutr. 2002, 132:2525-2531.
20. Fleet J.C., Andrews G.K., McCormick C.C. Iron-induced metallothionein in Chick liver: a rapid, route-dependent effect independent of zinc status. J. Nutr. 1990, 120:1214-1222.
21. Goldhaber S.B. Trace element risk assessment: essentiality vs toxicity. Regul. Toxicol. Pharmacol. 2003, 38:232-242.
22. Good M., Vasak M. Iron(II)-substituted metallothionein: evidence for the existence of iron-thiolate clusters. Biochemistry 1986, 25:8353-8356.
23. Guengerich F.P. Forging the link between metabolism and carcinogenesis. Mutat. Res. 2001, 488:195-209.
24. Hamer D.H. Metallothionein. Ann. Rev. Biochem. 1986, 55:913-951.
25. Hayakawa N., Enomoto S., Hirunuma R., Endo K., Ambe S., Ambe F. Metabolic study of trace elements in liver cancer bearing rat. J. Inorg. Biochem. 1997, 67:29-129.
26. Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat. Res. 2003, 533:153-171.
27. IARC p-Dimethylaminoazobenzene. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Some Aromatic Azo Compounds 1945, vol. 8. International Agency for Research on Cancer, Lyon, France, pp. 129-130.
28. Kagi J.H.R., Shaffer A. Biochemistry of metallothionein. Biochemistry 1988, 27:8509-8515.
29. Kang J.O., Jones C., Brothwell B. Toxicity associated with iron overload found in hemochromatosis: possible mechanism in a rat model. Clin. Lab. Sci. 1998, 11:350-354.
30. Kasai H., Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 1984, 12:2137-2145.
31. Kitagawa T., Sugano H. Enhancement of azo-dye induced hepatocarcinogenesis with dietary phenobarbital in rats. Gann 1977, 68:255-256.
32. Klaunig J.E., Xu Y., Isenberg J.S., Bachauski S., Kolaja K.L., Jiang J., Stevenson D.E., Walborg E.F. The role of oxidative stress in chemical carcinogenesis. Environ. Health Perspect. 1998, 106:289-295.
33. Kondo Y., Himeno S., Endo W., Mita M., Suzuki Y., Nemoto K., Akimoto M., Lazo J.S., Imura N. Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl) nitrosamine in mice. Carcinogenesis 1999, 20:1625-1627.
34. Ling C.R., Foster M.A. DAB-induced changes in NMR relaxation times, water and iron content of rat tissue. Br. J. Cancer 1980, 42:148-152.
35. Lowry O.H., Rosenbrough N.J., Lewis F.A., Randall R.J. Protein measurement with the folin-phenol reagent. J. Biol. Chem. 1951, 193:265-275.
36. Manjeswar S., Laconi E., Sheik A., Rao P.M., Rajalakshmi S., Sharma D.S. In vitro and in vivo response of hepatocytes from hepatic nodules to the mitoinhibitory effects of phenobarbital. Carcinogenesis 1994, 15:1963-1968.
37. Margoshes M., Vallee B.L. A cadmium protein from equine kidney cortex. J. Am. Chem. Soc. 1957, 79:4813-4814.
38. Mertz W. Review of the scientific basis for establishing the essentiality of trace elements. Biol. Trace Elem. Res. 1998, 66:185-191.
39. National Research Council, 1985. Guide for the care and use of laboratory animals, Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Commission on Life Sciences. NIH Publication No. 85-23. United States Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD.
40. Nesnow S., Argus M., Bergman H., Chu K., Frith C., Helmes T., Mcgaughy R., Ray V., Slaga Tj., Tennant R., Weisburger E. Chemical carcinogenesis: a review and analysis of the literature of selected chemicals and the establishment of the gene-tox carcinogen data base: a report of the US. Environmental Protection Agency gen-tox program. Mutat. Res. 1987, 185:1-195.
41. Niederau C., Fisher R., Sonnenberg A., Stremmel W., Trampisch H.J., Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatisis. N. Engl. J. Med. 1985, 313:1256-1262.
42. Nims R.W., Lubet R.A., Jones C.R., Mellini D.W., Thomas P.E. Comparative pharmacodynamics of CYP2B induction by phenobarbital in the male and female F344/NCr rat. Biochem. Pharmacol. 1993, 45:521-526.
43. Okado-Matsumoto A., Fridovich I. Subcellular distribution of superoxide dismutase (SOD) in rat liver. J. Biol. Chem. 2001, 276:38388-38393.
44. Oliveira P.A., Colaço A., Chaves R., Guedes-Pinto H., De-La-Cruz P.L.F., Lopes C. chemical carcinogenesis. An. Acad. Bras. Cienc. 2007, 79:593-616.
45. Paoletti F., Aldinucci D., Mocali A., Caparrini A.A. Sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal. Biochem. 1986, 154:536-541.
46. Pathak S., Khuda-Bukhsh A.R. Assessment of hepatocellular damage and hematological alterations in mice chronically fed p-dimethyl aminoazobenzene and phenobarbital. Exp. Mol. Pathol. 2007, 83:104-111.
47. Perera M.I.R., Betschart J.M., Virji M.A., Katyal S.L., Shinozuka H. Free radical injury and liver tumor promotion. Toxicol. Pathol. 1987, 15:51-59.
48. Poirier L.A. An introduction to selected concepts in metal carcinogenesis. Toxicology of Metals 1996, 287-298. Lewis publisher, New York. L.W. Chang (Ed.).
49. Sreedhar B., Nair K.M. Modulation of aconitase, metallothionein, and oxidative stress in zinc-deficient rat intestine during zinc and iron repletion. Free Radic. Biol. Med. 2005, 39:999-1008.
50. Staubli A., Boelsterli U.A. The labile iron pool in hepatocytes: prooxidant-induced increase in free iron precedes oxidative cell injury. Am. J. Physiol. 1998, 274:G1031-G1037.
51. Storey M.L., Greger J.L. Iron, zinc and copper interactions: chronic versus acute responses of rats. J. Nutr. 1987, 117:1434-1442.
52. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 1996, 20:553-566.
53. Valko M., Morris H., Cronin M.T.D. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12:1161-1208.
54. Ward J.M., Shibata M.-A., Devor D.E. Emerging issues in mouse liver carcinogenesis. Toxicol. Pathol. 1996, 24:129-137.
55. Wiseman H., Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: a role in inflamatory disease and progression to cancer. Biochem. J. 1996, 313:17-29.
56. Yasutake A., Hirayama K. Effect of iron overload on hepatic and renal metallothionein levels in rats. J. Health Sci. 2004, 50:372-378.